Cited by 1,089Genetic Neurodegenerative DiseasesGenetic factors in colorectal cancerGenetics and Neurodevelopmental Disorders

The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.

Trinucleotide repeat length instability and age of onset in Huntington's disease

Duyao, M., Ambrose, C., Myers, R., Novelletto, A., Persichetti, F., Frontali, M., Folstein, S., Ross, C., Franz, M., Abbott, M., Gray, J., Conneally, P., Young, A., Penney, J., Hollingsworth, Z., Shoulson, I., Lazzarini, A., Falek, A., Koroshetz, W., Sax, D., Bird, E., Vonsattel, J., Bonilla, E., Alvir, J., Bickham Conde, J., Cha, J.-H., Dure, L., Gomez, F., Ramos, M., Sanchez-Ramos, J., Snodgrass, S., de Young, M., Wexler, N., Moscowitz, C., Penchaszadeh, G., MacFarlane, H., Anderson, M., Jenkins, B., Srinidhi, J., Barnes, G., Gusella, J., MacDonald, M.·1993·Nature Genetics

DOI 10.1038/ng0893-387

Open this paper in CoChat — free account

Abstract

The initial observation of an expanded and unstable trinucleotide repeat in the Huntington's disease gene has now been confirmed and extended in 150 independent Huntington's disease families. HD chromosomes contained 37-86 repeat units, whereas normal chromosomes displayed 11-34 repeats. The HD repeat length was inversely correlated with the age of onset of the disorder. The HD repeat was unstable in more than 80% of meiotic transmissions showing both increases and decreases in size with the largest increases occurring in paternal transmissions. The targeting of spermatogenesis as a particular source of repeat instability is reflected in the repeat distribution of HD sperm DNA. The analysis of the length and instability of individual repeats in members of these families has profound implications for presymptomatic diagnosis.

Integrity signals

Registry

Crossref · 10.1038/ng0893-387

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes
MACDONALD, M. (1993) · Cell · doi:10.1016/0092-8674(93)90585-e · Cited by 8,366
Self-citation
Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome
Verkerk, A. J. M. H., Pieretti, M., Sutcliffe, J. S., Fu, Y.-H., Kuhl, D. P. A., Pizzuti, A., Reiner, O., Richards, S., Victoria, M. F., Zhang, F., et al. (1991) · Cell · doi:10.1016/0092-8674(91)90397-h · Cited by 3,481
A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group.
Shah, M. A., Datson, N. A., Srinidhi, L., Stanton, V. P., MacDonald, M. E., Allard, M. W., Youngman, S., Am, F., Mott, R., Draths, K., et al. (1993) · Cell · Cited by 3,055
Self-citation
Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy
Spada, A. L., Wilson, E. M., Lubahn, D. B., Harding, A., & Fischbeck, K. (1991) · Nature · doi:10.1038/352077a0 · Cited by 2,801
Molecular basis of myotonic dystrophy: Expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member
Brook, J. D., McCurrach, M. E., Harley, H. G., Buckler, A., Church, D. M., Aburatani, H., Hunter, K. W., Stanton, V. P., Thirion, J., Hudson, T. J., et al. (1992) · Cell · doi:10.1016/0092-8674(92)90154-5 · Cited by 2,754
A polymorphic DNA marker genetically linked to Huntington's disease
Gusella, J. F., Wexler, N. S., Conneally, P. M., Naylor, S. L., Anderson, M. A., Tanzi, R. E., Watkins, P. C., Ottina, K. A., Wallace, M. R., Sakaguchi, A. Y., et al. (1983) · Nature · doi:10.1038/306234a0 · Cited by 2,340
Self-citation
Variation of the CGG repeat at the fragile X site results in genetic instability: Resolution of the Sherman paradox
Fu, Y.-H., Kuhl, D. P. A., Pizzuti, A., Pieretti, M., Sutcliffe, J. S., Richards, S., Verkert, A. J. M. H., Holden, J. J. A., Fenwick, R. G., Warren, S. T., et al. (1991) · Cell · doi:10.1016/0092-8674(91)90283-5 · Cited by 2,080
Myotonic Dystrophy Mutation: an Unstable CTG Repeat in the 3′ Untranslated region of the Gene
Mahadevan, M. S., Tsilfidis, C., Sabourin, L. A., Shutler, G., Amemiya, C. T., Jansen, G., Neville, C., Narang, M. A., Barceló, J. M., O'Hoy, K., et al. (1992) · Science · doi:10.1126/science.1546325 · Cited by 1,656
Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1
Orr, H. T., Chung, M.-Y., Banfi, S., Kwiatkowski, T. J., Servadio, A., Beaudet, A. L., McCall, A. E., Duvick, L. A., Ranum, L. P. W., & Zoghbi, H. Y. (1993) · Nature Genetics · doi:10.1038/ng0793-221 · Cited by 1,632
An Unstable Triplet Repeat in a Gene Related to Myotonic Muscular Dystrophy
Fu, Y., Pizzuti, A., Fenwick, R. G., King, J., Rajnarayan, S., Dunne, P. W., Dubel, J., Nasser, G. A., Ashizawa, T., de Jong, P., et al. (1992) · Science · doi:10.1126/science.1546326 · Cited by 1,453

Flagged first, then by citations

Show all 35 references

Research works printed but not linked: 1

SAS/STAT User's Guide, Version 6, 4th edn, Vol.2 (SAS Institute Inc., Cary, North Carolina, 1989).

Sorted by citations

Items 401–500 of 998

HUNTINGTON'S DISEASE
Haddad, M. S., & Cummings, J. L. (1997) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(05)70345-2 · Cited by 48
Melatonin profiles and sleep characteristics in boys with fragile X syndrome: A preliminary study
Gould, E. L., Loesch, D. Z., Martin, M. J., Hagerman, R. J., Armstrong, S. M., & Huggins, R. (2000) · American Journal of Medical Genetics · doi:10.1002/1096-8628(20001211)95:4 · Cited by 101
Self-citation
Structural features of trinucleotide repeats associated with DNA expansion
Kovtun, I. V., Goellner, G. M., & McMurray, C. T. (2001) · Biochemistry and Cell Biology · doi:10.1139/o01-101 · Cited by 48
Cannabinoid CB2 Receptors in Neurodegenerative Proteinopathies: New Insights and Therapeutic Potential
Vuić, B., Milos, T., Tudor, L., Konjevod, M., Perković, M. N., Jembrek, M. J., Erjavec, G. N., & Štrac, D. Š. (2022) · Biomedicines · doi:10.3390/biomedicines10123000 · Cited by 49
Atypical Patterns of Inheritance
Gropman, A. L., & Adams, D. R. (2007) · Seminars in Pediatric Neurology · doi:10.1016/j.spen.2006.11.007 · Cited by 47
Upcoming Meetings Related to Huntington's Disease
Glajch, K. E., & Sadri‐Vakili, G. (2015) · Journal of Huntington s Disease · doi:10.3233/jhd-159001 · Cited by 47
Spinocerebellar ataxia type 17: Extension of phenotype with putaminal rim hyperintensity on magnetic resonance imaging
Loy, C. T., Sweeney, M. G., Davis, M. B., Wills, A. J., Sawle, G. V., Lees, A. J., & Tabrizi, S. J. (2005) · Movement Disorders · doi:10.1002/mds.20529 · Cited by 47
Antisense oligonucleotide–mediated MSH3 suppression reduces somatic CAG repeat expansion in Huntington’s disease iPSC–derived striatal neurons
Bunting, E. L., Donaldson, J., Cumming, S. A., Olive, J. F., Broom, E. L., Miclăuș, M., Hamilton, J., Tegtmeyer, M., Zhao, H. T., Brenton, J., et al. (2025) · Science Translational Medicine · doi:10.1126/scitranslmed.adn4600 · Cited by 48
Dentatorubral-pallidoluysian atrophy or Naito-Oyanagi disease
Kanazawa, I. (1998) · Neurogenetics · doi:10.1007/s100480050046 · Cited by 46
Different phenotypic expression in monozygotic twins with Huntington disease
Anca‐Herschkovitsch, M., Gazit, E., Loewenthal, R., Ostrovsky, O., Frydman, M., & Giladi, N. (2003) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.20328 · Cited by 46
Selection and Slippage Creating Serine Homopolymers
Huntley, M. A., & Golding, G. B. (2006) · Molecular Biology and Evolution · doi:10.1093/molbev/msl073 · Cited by 46
Identification of an expanded CAG repeat in the Huntington's disease gene (IT15) in a family reported to have benign hereditary chorea.
MacMillan, J., Morrison, P. J., Nevin, N. C., Shaw, D. J., Harper, P. S., Quarrell, O. W. J., & Snell, R. G. (1993) · Journal of Medical Genetics · doi:10.1136/jmg.30.12.1012 · Cited by 46
Onset and pre-onset studies to define the Huntington’s disease natural history
Squitieri, F., Cannella, M., Giallonardo, P., Maglione, V., Mariotti, C., & Hayden, M. R. (2001) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00648-7 · Cited by 46
siRNA Therapeutics: Future Promise for Neurodegenerative Diseases
Amiri, A., Barreto, G. E., Sathyapalan, T., & Sahebkar, A. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210402104054 · Cited by 46
Progressive cardiac arrhythmias and ECG abnormalities in the Huntington’s disease BACHD mouse model
Zhu, Y., Shamblin, I., Rodriguez, E., Salzer, G., Araysi, L. M., Margolies, K. A., Halade, G. V., Litovsky, S. H., Pogwizd, S. M., Gray, M., et al. (2019) · Human Molecular Genetics · doi:10.1093/hmg/ddz295 · Cited by 44
Astrocytic contributions to Huntington's disease pathophysiology
Khakh, B. S., & Goldman, S. A. (2023) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14977 · Cited by 49
Epigenetic modifications in trinucleotide repeat diseases
Evans‐Galea, M. V., Hannan, A. J., Carrodus, N. L., Delatycki, M. B., & Saffery, R. (2013) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2013.07.007 · Cited by 48
Huntington's disease in Greece: the experience of 14 years
Πάνας, Μ., Karadima, G., Vassos, E., Kalfakis, N., Kladi, A., Christodoulou, K., & Vassilopoulos, D. (2010) · Clinical Genetics · doi:10.1111/j.1399-0004.2010.01603.x · Cited by 44
The Accuracy, Feasibility and Challenges of Sequencing Short Tandem Repeats Using Next-Generation Sequencing Platforms
Závodná, M., Bagshaw, A., Bräuning, R., & Gemmell, N. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0113862 · Cited by 44
Analysis of triplet repeats in the huntingtin gene in Japanese families affected with Huntington's disease.
Masuda, N., Goto, J., Murayama, N., Watanabe, M., Kondo, I., & Kanazawa, I. (1995) · Journal of Medical Genetics · doi:10.1136/jmg.32.9.701 · Cited by 44
Population-specific genetic modification of Huntington's disease in Venezuela
Chao, M. J., Kim, K., Shin, J. W., Lucente, D. E., Wheeler, V. C., Li, H., Roach, J. C., Hood, L., Wexler, N. S., Jardim, L. B., et al. (2018) · PLoS Genetics · doi:10.1371/journal.pgen.1007274 · Cited by 44
Self-citation
A probabilistic disease progression modeling approach and its application to integrated Huntington’s disease observational data
Sun, Z., Ghosh, S., Li, Y., Cheng, Y., Mohan, A., Sampaio, C., & Hu, J. (2019) · JAMIA Open · doi:10.1093/jamiaopen/ooy060 · Cited by 42
Huntington's disease
Ross, C. A., & Margolis, R. L. (2001) · Clinical Neuroscience Research · doi:10.1016/s1566-2772(00)00014-1 · Cited by 44
Self-citation
Gene expression profile in fibroblasts of Huntington's disease patients and controls
Marchina, E., Misasi, S., Bozzato, A., Ferraboli, S., Agosti, C., Rozzini, L., Borsani, G., Barlati, S., & Padovani, A. (2013) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2013.11.014 · Cited by 43
Depressive symptoms in prodromal Huntington's Disease correlate with Stroop-interference related functional connectivity in the ventromedial prefrontal cortex
Unschuld, P. G., Joel, S. E., Pekar, J. J., Reading, S. A. J., Oishi, K., McEntee, J., Shanahan, M. R., Bakker, A., Margolis, R. L., Bassett, S. S., et al. (2012) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2012.01.002 · Cited by 44
Self-citation
Exploding the Repeat Length Paradigm while Exploring Amyloid Toxicity in Huntington’s Disease
Wetzel, R. B. (2020) · Accounts of Chemical Research · doi:10.1021/acs.accounts.0c00450 · Cited by 40
Hand tapping: A simple, reproducible, objective marker of motor dysfunction in Huntington’s disease
Michell, A. W., Goodman, A. O. G., Silva, A. H. D., Lazic, S. E., Morton, A. J., & Barker, R. (2008) · Journal of Neurology · doi:10.1007/s00415-008-0859-x · Cited by 43
Malonate and 3‐Nitropropionic Acid Neurotoxicity Are Reduced in Transgenic Mice Expressing a Caspase‐1 Dominant‐Negative Mutant
Andreassen, O. A., Ferrante, R. J., Hughes, D. B., Klivènyi, P., Dedeoglu, A., Ona, V. O., Friedlander, R. M., & Beal, M. F. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0750847.x · Cited by 43
Analysis of CAG Repeat of the Machado-Joseph Gene in Human, Chimpanzee and Monkey Populations: A Variant Nucleotide is Associated with the Number of CAG Repeats
Limprasert, P., Nouri, N., Heyman, R. A., Nopparatana, C., Kamonsilp, M., Deininger, P. L., & Keats, B. J. B. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.2.207 · Cited by 43
Huntington's Disease: Advocacy Driving Science
Wexler, N. S. (2011) · Annual Review of Medicine · doi:10.1146/annurev-med-050710-134457 · Cited by 40
Self-citation
Blue light therapy improves circadian dysfunction as well as motor symptoms in two mouse models of Huntington's disease
Wang, H. B., Whittaker, D. S., Truong, D. A., Mulji, A., Ghiani, C. A., Loh, D. H., & Colwell, C. S. (2017) · Neurobiology of Sleep and Circadian Rhythms · doi:10.1016/j.nbscr.2016.12.002 · Cited by 43
Modular probes for enriching and detecting complex nucleic acid sequences
Wang, J. S., Yan, Y. H., & Zhang, D. Y. (2017) · Nature Chemistry · doi:10.1038/nchem.2820 · Cited by 42
Confidence intervals for predicted age of onset, given the size of (CAG) n repeat, in Huntington's disease
Lucotte, G., Turpin, J. C., Rieß, O., Epplen, J. T., Siedlaczck, I., Loirat, F., & Hazout, S. (1995) · Human Genetics · doi:10.1007/bf00209410 · Cited by 42
Motor–Language Coupling in Huntington’s Disease Families
Kargieman, L., Herrera, E., Báez, S., García, A. M., Dottori, M., Gelormini‐Lezama, C., Manes, F. F., Gershanik, O. S., & Ibáñez, A. M. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00122 · Cited by 43
Amelioration of Huntington's disease phenotypes by Beta-Lapachone is associated with increases in Sirt1 expression, CREB phosphorylation and PGC-1α deacetylation
Lee, M., Ban, J.-J., Chung, J. Y., Im, W., & Kim, M. (2018) · PLoS ONE · doi:10.1371/journal.pone.0195968 · Cited by 42
Genetic polymorphisms adjacent to the CAG repeat influence clinical features at onset in Huntington's disease
Vuillaume, I., Vermersch, P., Destée, A., Petit, H., & Sablonnière, B. (1998) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.64.6.758 · Cited by 41
Huntington Disease in Asia
Xu, M., & Wu, Z. (2015) · Chinese Medical Journal · doi:10.4103/0366-6999.159359 · Cited by 40
Ubiquilin-1 Overexpression Increases the Lifespan and Delays Accumulation of Huntingtin Aggregates in the R6/2 Mouse Model of Huntington's Disease
Safren, N., Ayadi, A. E., Chang, L., Terrillion, C. E., Gould, T. D., Boehning, D. F., & Monteiro, M. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087513 · Cited by 40
Modeling Huntington׳s disease with patient-derived neurons
Mattis, V. B., & Svendsen, C. N. (2015) · Brain Research · doi:10.1016/j.brainres.2015.10.001 · Cited by 40
Study of three intragenic polymorphisms in the Machado-Joseph disease gene (MJD1) in relation to genetic instability of the (CAG)n tract
Maciel, P., Gaspar, C., Guimarães, L., Goto, J., Lopes‐Cendes, Í., Hayes, S. M., Arvidsson, K., Dias, A., Sequeiros, J., Sousa, A., et al. (1999) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5200264 · Cited by 40
Targeting N-Methyl-d-Aspartate Receptors in Neurodegenerative Diseases
Carles, A., Freyssin, A., Perin-Dureau, F., Rubinstenn, G., & Maurice, T. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25073733 · Cited by 47
Cause or compensation?—Altered neuronal Ca2+ handling in Huntington's disease
Mackay, J. P., Nassrallah, W. B., & Raymond, L. A. (2018) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12817 · Cited by 40
Spinocerebellar Ataxia Type 17 (SCA17)
Toyoshima, Y., & Takahashi, H. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-71779-1_10 · Cited by 41
Failure of Ubiquitin Proteasome System: Risk for Neurodegenerative Diseases
Chen, Z., Geetha, T., & Babu, J. R. (2014) · Neurodegenerative Diseases · doi:10.1159/000367694 · Cited by 42
Trinucleotide repeats (CGG) 22 TGG(CGG) 43 TGG(CGG) 21 from the fragile X gene remain stable in transgenic mice
Lavedan, C. N., Garrett, L. J., & Nussbaum, R. L. (1997) · Human Genetics · doi:10.1007/s004390050525 · Cited by 39
Molecular Genetics of Neurological Diseases
Martin, J. B. (1993) · Science · doi:10.1126/science.8235586 · Cited by 38
Role of the repeat expansion size in predicting age of onset and severity in RFC1 disease
Curró, R., Dominik, N., Facchini, S., Vegezzi, E., Sullivan, R., Deforie, V. G., Fernández‐Eulate, G., Traschütz, A., Rossi, S., Garibaldi, M., et al. (2024) · Brain · doi:10.1093/brain/awad436 · Cited by 42
Artificial miRNAs Targeting Mutant Huntingtin Show Preferential Silencing In Vitro and In Vivo
Mas, A., Wilson, M. J., Boudreau, R. L., Spengler, R. M., & Davidson, B. L. (2015) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2015.7 · Cited by 38
Gender Differences in Non-sex Linked Disorders: Insights From Huntington's Disease
Zielonka, D., & Stawińska-Witoszyńska, B. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00571 · Cited by 38
Modulating huntingtin half‐life alters polyglutamine‐dependent aggregate formation and cell toxicity
Kaytor, M. D., Wilkinson, K. D., & Warren, S. T. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02376.x · Cited by 38
What transgenic mice tell us about neurodegenerative disease
Gurney, M. E. (2000) · BioEssays · doi:10.1002/(sici)1521-1878(200003)22:3 · Cited by 38
Prion-Like Propagation of Protein Aggregation and Related Therapeutic Strategies
Kaufman, S. K., & Diamond, M. I. (2013) · Neurotherapeutics · doi:10.1007/s13311-013-0196-3 · Cited by 40
Use of human stem cells in Huntington disease modeling and translational research
Golas, M. M., & Sander, B. O. (2016) · Experimental Neurology · doi:10.1016/j.expneurol.2016.01.021 · Cited by 37
Huntington's disease: Molecular basis of pathology and status of current therapeutic approaches
Huang, W., Chen, W., & Zhang, X. (2016) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2016.3566 · Cited by 37
Arginine in C9ORF72 Dipolypeptides Mediates Promiscuous Proteome Binding and Multiple Modes of Toxicity
Radwan, M., Ang, C., Ormsby, A. R., Cox, D., Daly, J. C., Reid, G. E., & Hatters, D. M. (2020) · Molecular & Cellular Proteomics · doi:10.1074/mcp.ra119.001888 · Cited by 39
P2X7 Receptor Upregulation in Huntington’s Disease Brains
Ollà, I., Santos‐Galindo, M., Elorza, A., & Lucas, J. J. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.567430 · Cited by 42
Disruption of response inhibition circuits in prodromal Huntington disease
Rao, J. A., Harrington, D. L., Durgerian, S., Reece, C., Mourany, L., Koenig, K. A., Lowe, M. J., Magnotta, V. A., Long, J. D., Johnson, H. J., et al. (2014) · Cortex · doi:10.1016/j.cortex.2014.04.018 · Cited by 37
The CAG repeat at the Huntington disease gene in the Portuguese population: insights into its dynamics and to the origin of the mutation
Costa, M. D. C., Magalhães, P. M. R., Guimarães, L., Maciel, P., Sequeiros, J., & Sousa, A. (2005) · Journal of Human Genetics · doi:10.1007/s10038-005-0343-8 · Cited by 37
Evidence for Prion-Like Mechanisms in Several Neurodegenerative Diseases: Potential Implications for Immunotherapy
Marciniuk, K., Taschuk, R., & Napper, S. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/473706 · Cited by 39
7 Mechanisms of Genomic Imprinting in Mammals
Cold, J. D., & Pedersen, R. A. (1994) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/s0070-2153(08)60552-9 · Cited by 37
Mutation size and age at onset in Huntington's disease.
Craufurd, D., & Dodge, A. (1993) · Journal of Medical Genetics · doi:10.1136/jmg.30.12.1008 · Cited by 37
MicroRNA-27a reduces mutant hutingtin aggregation in an in vitro model of Huntington's disease
Ban, J.-J., Chung, J.-Y., Lee, M., Im, W., & Kim, M. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.05.040 · Cited by 36
Polyglutamine Repeats Are Associated to Specific Sequence Biases That Are Conserved among Eukaryotes
Ramazzotti, M., Monsellier, É., Kamoun, C., Degl’Innocenti, D., & Melki, R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030824 · Cited by 35
Huntington’s Disease—An Outlook on the Interplay of the HTT Protein, Microtubules and Actin Cytoskeletal Components
Taran, A., Belikova, L. D., Lagarkova, M. A., & Alieva, I. B. (2020) · Cells · doi:10.3390/cells9061514 · Cited by 37
The Role of the Immune System in Triplet Repeat Expansion Diseases
Olejniczak, M., Urbanek-Trzeciak, M. O., & Krzyżosiak, W. J. (2015) · Mediators of Inflammation · doi:10.1155/2015/873860 · Cited by 40
Correlation between magnitude of CAG repeat length alterations and length of the paternal repeat in paternally inherited Huntington's disease
Nørremølle, A., Sørensen, S. A., Fenger, K., & Hasholt, L. (1995) · Clinical Genetics · doi:10.1111/j.1399-0004.1995.tb03941.x · Cited by 36
Epigenetics and Triplet-Repeat Neurological Diseases
Nageshwaran, S., & Festenstein, R. (2015) · Frontiers in Neurology · doi:10.3389/fneur.2015.00262 · Cited by 36
Microsatellite and trinucleotide-repeat evolution: evidence for mutational bias and different rates of evolution in different lineages
Rubinsztein, D. C., Amos, B., & Cooper, G. (1999) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.1999.0465 · Cited by 36
Instability of the CAG repeat in immortalized fibroblast cell cultures from Huntington's Disease transgenic mice1Published on the World Wide Web on 15 April 1999.1
MANLEY, K. M., Pugh, J., & Messer, A. C. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01451-1 · Cited by 36
Family history and DNA analysis in patients with suspected Huntington's disease
Siesling, S. (2000) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.69.1.54 · Cited by 36
Chapter 28 Pathogenesis of neurodegenerative diseases associated with expanded glutamine repeats: New answers, new questions
Ross, C. A., Margolis, R. L., Bêcher, M. W., Wood, J. D., Engelender, S., Cooper, J. K., & Sharp, A. H. (1998) · Progress in brain research · doi:10.1016/s0079-6123(08)64029-7 · Cited by 36
Self-citation
Psychiatric genetics: Research challenges and pathways forward
Rutter, M. L. (1994) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320540305 · Cited by 36
Early detection of exon 1 huntingtin aggregation in zQ175 brains by molecular and histological approaches
Smith, E. J., Sathasivam, K., Landles, C., Osborne, G. F., Mason, M. A., Gomez-Paredes, C., Taxy, B. A., Milton, R. E., Ast, A., Schindler, F., et al. (2022) · Brain Communications · doi:10.1093/braincomms/fcad010 · Cited by 35
Quality Control in Huntington’s Disease: a Therapeutic Target
Nand, S., Singh, B. K., Rathore, A. S., Zahra, W., Keswani, C., Birla, H., Singh, S. S., Dilnashin, H., & Singh, S. P. (2019) · Neurotoxicity Research · doi:10.1007/s12640-019-00087-x · Cited by 35
Sex-dependent Effect of BAG1 in Ameliorating Motor Deficits of Huntington Disease Transgenic Mice
Orr, A. L., Huang, S., Redd, M. A., Reed, J. C., Li, S., & Li, X. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m710606200 · Cited by 35
Prefrontal executive function associated coupling relates to Huntington's disease stage
Unschuld, P. G., Liu, X., Shanahan, M. R., Margolis, R. L., Bassett, S. S., Brandt, J., Schretlen, D. J., Redgrave, G. W., Hua, J., Höck, C., et al. (2013) · Cortex · doi:10.1016/j.cortex.2013.05.015 · Cited by 36
Self-citation
Molecular diagnosis of Huntington disease in Brazilian patients
SILVA, T. C. L. E., Serra, H. G., Bertuzzo, C. S., & Lopes‐Cendes, Í. (2000) · Arquivos de Neuro-Psiquiatria · doi:10.1590/s0004-282x2000000100002 · Cited by 35
Predictability of Age at Onset in Huntington Disease in the Dutch Population
Maat‐Kievit, A., Losekoot, M., Zwinderman, A. H., der Vlis, M. V.-V., Belfroid, R. D. M., LOPEZ, F., van Ommen, G. B., Breuning, M. H., & Roos, R. A. C. (2002) · Medicine · doi:10.1097/00005792-200207000-00001 · Cited by 35
Ethical and social issues in presymptomatic testing for Huntington's disease: a European Community collaborative study. European Community Huntington's Disease Collaborative Study Group.
(1993) · Journal of Medical Genetics · doi:10.1136/jmg.30.12.1028 · Cited by 35
The Genetic Modifiers of Motor OnsetAge (GeM MOA) Website: Genome-wide Association Analysis for Genetic Modifiers of Huntington’s Disease
Correia, K., Harold, D. H., Kim, K., Holmans, P., Jones, L., Orth, M., Myers, R. H., Kwak, S., Wheeler, V. C., MacDonald, M. E., et al. (2015) · Journal of Huntington s Disease · doi:10.3233/jhd-150169 · Cited by 34
Self-citation
Metabolism in Huntington’s disease: a major contributor to pathology
Singh, A., & Agrawal, N. (2021) · Metabolic Brain Disease · doi:10.1007/s11011-021-00844-y · Cited by 34
Age-, tissue- and length-dependent bidirectional somatic CAG•CTG repeat instability in an allelic series of R6/2 Huntington disease mice
Larson, E., Fyfe, I., Morton, A. J., & Monckton, D. G. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.01.004 · Cited by 38
Elongated CAG repeats of the B37 gene in a Danish family with dentato-rubro-pallido-luysian atrophy
N�rrem�lle, A., Nielsen, J. E., S�rensen, S. A., & Hasholt, L. (1995) · Human Genetics · doi:10.1007/bf00225200 · Cited by 34
Trinucleotide repeats in neurologic diseases: An hypothesis concerning the pathogenesis of Huntington's disease, Kennedy's disease, and spinocerebellar ataxia type I
Cha, J.-H. J., & Dure, L. S. (1994) · Life Sciences · doi:10.1016/0024-3205(94)90012-4 · Cited by 34
Self-citation
Huntington disease: somatic expansion, pathobiology and therapeutics
Donaldson, J., Moss, D. J. H., Ciosi, M., Usdin, K., Balmus, G., Monckton, D. G., & Tabrizi, S. J. (2025) · Nature Reviews Neurology · doi:10.1038/s41582-025-01159-7 · Cited by 36
Functional Connectivity of Primary Motor Cortex Is Dependent on Genetic Burden in Prodromal Huntington Disease
Koenig, K. A., Lowe, M. J., Harrington, D. L., Lin, J. Y., Durgerian, S., Mourany, L., Paulsen, J. S., Rao, S. M., & the PREDICT-HD Investigators of the Huntington Study Group (2014) · Brain Connectivity · doi:10.1089/brain.2014.0271 · Cited by 33
Genetic Contributors to Intergenerational CAG Repeat Instability in Huntington’s Disease Knock-In Mice
Neto, J. L., Lee, J., Afridi, A., Gillis, T., Guide, J. R., Dempsey, S., Lager, B., Alonso, I. D. C. M. P., Wheeler, V. C., & Pinto, R. M. (2016) · Genetics · doi:10.1534/genetics.116.195578 · Cited by 35
The Nt17 Domain and its Helical Conformation Regulate the Aggregation, Cellular Properties and Neurotoxicity of Mutant Huntingtin Exon 1
Vieweg, S., Mahul‐Mellier, A., Ruggeri, F. S., Riguet, N., DeGuire, S. M., Chiki, A., Cendrowska, U., Dietler, G., & Lashuel, H. A. (2021) · Journal of Molecular Biology · doi:10.1016/j.jmb.2021.167222 · Cited by 34
Cellular and molecular mechanisms involved in the selective vulnerability of striatal projection neurons in Huntington's disease.
Pérez‐Navarro, E., Canals, J. M., Ginés, S., & Alberch, J. (2006) · PubMed · doi:10.14670/hh-21.1217 · Cited by 34
Site of (CCG) polymorphism in the HD gene
Rubinsztein, D. C., Leggo, J., Barton, D. E., & Ferguson-Smith, M. A. (1993) · Nature Genetics · doi:10.1038/ng1193-214 · Cited by 33
A Platform to View Huntingtin Exon 1 Aggregation Flux in the Cell Reveals Divergent Influences from Chaperones hsp40 and hsp70
Ormsby, A. R., Ramdzan, Y. M., Mok, Y.-F., Jovanoski, K. D., & Hatters, D. M. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.486944 · Cited by 33
Live cell imaging and biophotonic methods reveal two types of mutant huntingtin inclusions
Caron, N. S., Hung, C. L.-K., Atwal, R. S., & Truant, R. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt625 · Cited by 32
Design of Bivalent Nucleic Acid Ligands for Recognition of RNA-Repeated Expansion Associated with Huntington’s Disease
Thadke, S. A., Perera, J. D. R., Hridya, V. M., Bhatt, K. S., Shaikh, A. Y., Hsieh, W., Chen, M., Gayathri, C., Gil, R. R., Rule, G. S., et al. (2018) · Biochemistry · doi:10.1021/acs.biochem.8b00062 · Cited by 33
Psychosis and longitudinal outcomes in Huntington disease: the COHORT Study
Connors, M. H., Teixeira-Pinto, A. M., & Loy, C. T. (2019) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2019-320646 · Cited by 33
Approaches to Sequence the HTT CAG Repeat Expansion and Quantify Repeat Length Variation
Ciosi, M., Cumming, S. A., Chatzi, A., Larson, E., Tottey, W., Lomeikaite, V., Hamilton, G. M., Wheeler, V. C., Pinto, R. M., Kwak, S., et al. (2021) · Journal of Huntington s Disease · doi:10.3233/jhd-200433 · Cited by 32
Modifiers of Somatic Repeat Instability in Mouse Models of Friedreich Ataxia and the Fragile X-Related Disorders: Implications for the Mechanism of Somatic Expansion in Huntington’s Disease
Zhao, X.-N., Kumari, D., Miller, C. J., Kim, G.-Y., Hayward, B. E., Vitalo, A. G., Pinto, R. M., & Usdin, K. (2021) · Journal of Huntington s Disease · doi:10.3233/jhd-200423 · Cited by 32
Structural Basis of Huntingtin Fibril Polymorphism Revealed by Cryogenic Electron Microscopy of Exon 1 HTT Fibrils
Nazarov, S., Chiki, A., Boudeffa, D., & Lashuel, H. A. (2022) · Journal of the American Chemical Society · doi:10.1021/jacs.2c00509 · Cited by 31
Transgenic mouse models of neurodegenerative disease caused by CAG/polyglutamine expansions
Bates, G. P., & Davies, S. W. (1997) · Molecular Medicine Today · doi:10.1016/s1357-4310(97)01142-8 · Cited by 32
Striatal metabolism and psychomotor speed as predictors of motor onset in Huntington’s disease
Herben-Dekker, M., van Oostrom, J. C. H., Roos, R. A. C., Jurgens, C. K., Witjes‐Ané, M. W., Kremer, H. P. H., Leenders, K. L., & Spikman, J. M. (2014) · Journal of Neurology · doi:10.1007/s00415-014-7350-7 · Cited by 31
Estimating and disclosing the risk of developing Alzheimer‘s disease: challenges, controversies and future directions
Roberts, J. S., & Tersegno, S. M. (2010) · Future Neurology · doi:10.2217/fnl.10.31 · Cited by 32

Authors: Duyao, M., Ambrose, C., Myers, R., Novelletto, A., Persichetti, F., Frontali, M., Folstein, S., Ross, C., Franz, M., Abbott, M., Gray, J., Conneally, P., Young, A., Penney, J., Hollingsworth, Z., Shoulson, I., Lazzarini, A., Falek, A., Koroshetz, W., Sax, D., Bird, E., Vonsattel, J., Bonilla, E., Alvir, J., Bickham Conde, J., Cha, J.-H., Dure, L., Gomez, F., Ramos, M., Sanchez-Ramos, J., Snodgrass, S., de Young, M., Wexler, N., Moscowitz, C., Penchaszadeh, G., MacFarlane, H., Anderson, M., Jenkins, B., Srinidhi, J., Barnes, G., Gusella, J., & MacDonald, M.
Affiliations: Massachusetts General Hospital (US)
Boston University (US)
University of Rome Tor Vergata (IT)
Johns Hopkins University (US)
Indiana University (US)
University of Rochester Medicine (US)
Rutgers, The State University of New Jersey (US)
Emory University (US)
Harvard University (US)
Universidad del Zulia (VE)
Long Island Jewish Medical Center (US)
Kennedy Krieger Institute (US)
Hospital Virgen del Camino (ES)
University of Mississippi Medical Center (US)
Hereditary Disease Foundation (US)
ORCID: Myers, R.
Novelletto, A.
Persichetti, F.
Frontali, M.
Ross, C.
Shoulson, I.
Koroshetz, W.
Bonilla, E.
Dure, L.
Snodgrass, S.
Wexler, N.
Gusella, J.
Venue: Nature Genetics
Publisher: Springer Science and Business Media LLC
Published: 1993-08
Volume: 4
Issue: 4
Pages: 387-392
ISSN: 1061-4036 (ISSN-L)
1546-1718
DOI: 10.1038/ng0893-387
OpenAlex: W1994285647
Cited by: 1,089
References: 35
Citations by year: 2026: 17 · 2025: 27 · 2024: 37 · 2023: 23 · 2022: 39 · 2021: 42 · 2020: 36 · 2019: 38 · 2018: 35 · 2017: 42 · 2016: 26 · 2015: 35 · 2014: 31 · 2013: 39 · 2012: 47
FWCI: 17.83
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature Genetics (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (5r01ns017978-06)
National Institute of Neurological Disorders and Stroke (NS17978, NS16375, NS 16367)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
Keywords: Huntington's disease, trinucleotide repeat expansion, repeat instability, age of onset, paternal transmission, spermatogenesis, presymptomatic diagnosis, repeat length
MeSH terms: Adult, Age Factors, Female, Genetic Carrier Screening, Humans, Huntington Disease, Genetic Linkage, Male, Middle Aged, Pedigree, Repetitive Sequences, Nucleic Acid, Spermatozoa, Linkage Disequilibrium

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Trinucleotide repeat length instability and age of onset in Huntington's disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks